Eye on ESMO: Day Three – Merck & Co. wins big lung cancer battle
Merck unveils impressive data on Keytruda, trumping BMS’ Opdivo
X
Eye on ESMO: Day Three – Merck & Co. wins big lung cancer battle
https://pharmaphorum.com/esmo-2016/eye-esmo-day-three-merck-co-wins-big-lung-cancer-battle/